Sjoerd Schetters

Journal Article
A1
open access

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling

Karel Van Damme (UGent) , Dorine Sichien (UGent) , Katrien Van Der Borght (UGent) , Justine Van Moorleghem (UGent) , Sofie Van Gassen (UGent) , Joseph Jorssen, Seppe De Winter, Elisabeth De Leeuw (UGent) , Caihong Wang, Qingqing Chai, et al.

(2026) SCIENCE IMMUNOLOGY. 11(115).

Add to list

Innate type 2 lymphocytes trigger an inflammatory switch in alveolar macrophages

Stijn Verwaerde (UGent) , Jean-François Hastir (UGent) , Sjoerd Schetters (UGent) , Ursula Smole (UGent) , Leen Seys (UGent) , Antonio Pires da Silva Baptista (UGent) , Kieran English (UGent) , Martijn Schuijs (UGent) , Helena Catharine Aegerter (UGent) , Karel Van Damme (UGent) , et al.

(2026) IMMUNITY. 59(1). p.60-78

Add to list

Journal Article
A1
open access

Gut microbiota modulates CNS barrier function in murine model for multiple sclerosis

Junhua Xie, Marlies Burgelman (UGent) , Pieter Dujardin (UGent) , Jonas Castelein (UGent) , Griet Van Imschoot (UGent) , Elien Van Wonterghem (UGent) , Hannah Lernout (UGent) , Sjoerd Schetters (UGent) , Charysse Vandendriessche (UGent) , Lien Van Hoecke (UGent) , et al.

(2025) FLUIDS AND BARRIERS OF THE CNS. 22(1).

Add to list

Eosinophil responses in adaptive pulmonary type 2 immunity is locally regulated by interferon type 1 and-2

Sjoerd Schetters (UGent) , Stijn Verwaerde (UGent) , Julien Catherine, Sina Karimi, Sam Dupont (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Louis Boon, Florence Roufosse and Bart Lambrecht (UGent)

(2024) EUROPEAN JOURNAL OF IMMUNOLOGY. In European Journal of Immunology 54(Supplement 1). p.18-18

Add to list

Journal Article
A1
open access

S. mansoni-derived omega-1 prevents OVA-specific allergic airway inflammation via hampering of cDC2 migration

Thiago A. Patente, Thomas A. Gasan, Maaike Scheenstra, Arifa Ozir-Fazalalikhan, Katja Obieglo, Sjoerd Schetters (UGent) , Stijn Verwaerde (UGent) , Karl Vergote (UGent) , Frank Otto, Ruud H. P. Wilbers, et al.

(2024) PLOS PATHOGENS. 20(8).

Add to list

Journal Article
A1
open access

Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification

Joseph Jorssen, Glenn Van Hulst, Kirena Mollers, Julien Pujol, Georgios Petrellis, Antonio Pires da Silva Baptista (UGent) , Sjoerd Schetters (UGent) , Frederic Baron, Jo Caers, Bart Lambrecht (UGent) , et al.

(2024) IMMUNITY. 57(7). p.1549-1566.e8

Add to list

Miscellaneous
open access

The development and plasticity of myeloid immunity in the lung

Sjoerd Schetters (UGent) , Floris Dammeijer and Christophe J. Desmet

(2023) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Journal Article
A1
open access

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance

Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters (UGent) , Mike Eterman, Marit van Elsas, Joanne Mankor, Larissa Klaase, Marjolein de Bruijn, Menno van Nimwegen, Tim van Tienhoven, et al.

(2023) SCIENCE IMMUNOLOGY. 8(83).

Add to list

Journal Article
A1
open access

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel Van Damme (UGent) , Levi Hoste (UGent) , Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes, Liesbet Martens (UGent) , Roos Colman (UGent) , Robin Browaeys (UGent) , Cedric Bosteels (UGent) , Stijn Verwaerde (UGent) , et al.

(2023) SCIENCE TRANSLATIONAL MEDICINE. 15(710).

Add to list

Miscellaneous
open access

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel Van Damme (UGent) , Levi Hoste (UGent) , Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes, Liesbet Martens (UGent) , Roos Colman (UGent) , Robin Browaeys (UGent) , Cedric Bosteels (UGent) , Stijn Verwaerde (UGent) , et al.

(2023) medRxiv.

Academic Bibliography

Sjoerd Schetters

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling

Innate type 2 lymphocytes trigger an inflammatory switch in alveolar macrophages

Gut microbiota modulates CNS barrier function in murine model for multiple sclerosis

Eosinophil responses in adaptive pulmonary type 2 immunity is locally regulated by interferon type 1 and-2

S. mansoni-derived omega-1 prevents OVA-specific allergic airway inflammation via hampering of cDC2 migration

Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification

The development and plasticity of myeloid immunity in the lung

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Contents

Support

Contact